Willow Biosciences Inc. (TSX:WLLW)
0.0350
-0.0050 (-12.50%)
May 22, 2025, 2:26 PM EDT
Willow Biosciences Revenue
Willow Biosciences had revenue of 1.76M CAD in the quarter ending March 31, 2025, with 3,349.02% growth. This brings the company's revenue in the last twelve months to 6.37M, up 571.23% year-over-year. In the year 2024, Willow Biosciences had annual revenue of 4.66M with 297.78% growth.
Revenue (ttm)
6.37M
Revenue Growth
+571.23%
P/S Ratio
0.80
Revenue / Employee
335.26K
Employees
19
Market Cap
5.07M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.66M | 3.49M | 297.78% |
Dec 31, 2023 | 1.17M | 351.00K | 42.75% |
Dec 31, 2022 | 821.00K | 688.00K | 517.29% |
Dec 31, 2021 | 133.00K | 123.00K | 1,230.00% |
Dec 31, 2020 | 10.00K | 5.00K | 100.00% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Trulieve Cannabis | 1.71B |
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.58B |
Sienna Senior Living | 896.45M |
Extendicare | 1.47B |
Cronos Group | 179.08M |
WELL Health Technologies | 990.34M |
Curaleaf Holdings | 1.89B |